The Phase 2 data lock process - at 8000 feet Br
Post# of 72444
(Total Views: 529)
Posted On: 08/22/2021 9:31:22 AM
Re: justfactsmam #70168
The Phase 2 data lock process - at 8000 feet
Bravo well said justfactsmam, Having been a database administrator/ data analyst for 35+ years, I can tell you factually that the process of data transfer from multiple systems (many of which will likely be different operating systems / hardware ) is complex at two major levels.
One being each field of the the data transfer will require the following:
The field isn’t blank
The field has the correct data ( right data in the wrong place is bad data)
Then finally verification of the data and any corrections, validated. For example we know that the SOC in Russia is different than the USA SOC. How does that reflect in the overall picture.
Two , the differences between computer systems between Russian and English systems plus any differences in reporting forms and field comparisons may be an issue that requires reconciliation. For example we know what data the FDA is requiring, how is that match out to the Russian systems? In all likelihood the majority of these issues are worked out. But there’s always somebody that didn’t get the memo.
So IMO. I doubt these issues can harm the integrity of the phase2 process. But there is the possibility it may present opportunities to slow it down but by days not weeks or months.
IMHO, be patient , the last thing we want is a sloppy phase2 report.
Bravo well said justfactsmam, Having been a database administrator/ data analyst for 35+ years, I can tell you factually that the process of data transfer from multiple systems (many of which will likely be different operating systems / hardware ) is complex at two major levels.
One being each field of the the data transfer will require the following:
The field isn’t blank
The field has the correct data ( right data in the wrong place is bad data)
Then finally verification of the data and any corrections, validated. For example we know that the SOC in Russia is different than the USA SOC. How does that reflect in the overall picture.
Two , the differences between computer systems between Russian and English systems plus any differences in reporting forms and field comparisons may be an issue that requires reconciliation. For example we know what data the FDA is requiring, how is that match out to the Russian systems? In all likelihood the majority of these issues are worked out. But there’s always somebody that didn’t get the memo.
So IMO. I doubt these issues can harm the integrity of the phase2 process. But there is the possibility it may present opportunities to slow it down but by days not weeks or months.
IMHO, be patient , the last thing we want is a sloppy phase2 report.
(3)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Ronald A Phillips